AD
ADIA.US Adia Nutrition Inc
- Market cap
- USD 11.2M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is ADIA.US undervalued?
Graham numberThe Graham number of Adia Nutrition Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Adia Nutrition Inc fundamental analysis
No fundamental analysis for Adia Nutrition Inc yet.
Adia Nutrition Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Adia Nutrition Inc
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly…
Full company profileAdia Nutrition Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Adia Nutrition Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2002 | 2003 | 2004 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 415K | 760K | 197K | - | 6.38K | 701K | 1.32M |
| Gross Profit | 138K | 326K | 48.2K | - | 2.19K | 192K | 700K |
| Operating Income | -457K | -575K | -6.04M | -0.75 | -175K | -366K | -200K |
| EBITDA | - | - | - | - | -166K | -285K | -114K |
| Net Income | -458K | -597K | -8.61M | -0.75 | -181K | -395K | -244K |
| EPS | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||
| Total Assets | - | 226K | 2.99M | 0.50 | 666K | 595K | 744K |
| Total Liabilities | - | 394K | 1.77M | 1.25 | 641K | 853K | 1.12M |
| Shareholders' Equity | - | -168K | 1.21M | -0.75 | 25.5K | -258K | -380K |
| Cash & Short-term Investments | - | 0.00 | 0.00 | 0.50 | 6.32K | 79.4K | 128K |
| Total Debt | - | - | - | 1.25 | - | - | - |
| Cash Flow | |||||||
| Operating Cash Flow | 35.2K | -289K | -3.92M | -0.75 | -335K | -179K | -328K |
| Capital Expenditure | 14.5K | 25.0K | 68.2K | 0.00 | 26.0K | 13.2K | 11.0K |
| Free Cash Flow | - | - | - | -0.75 | -361K | -192K | -339K |
| Ratios | |||||||
| ROE | - | - | -710.6% | - | -709.0% | - | - |
| ROA | - | -263.9% | -288.4% | -150.0% | -27.2% | -66.5% | -32.8% |
| Net Profit Margin | -110.5% | -78.5% | -4,362.6% | - | -2,838.0% | -56.5% | -18.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Adia Nutrition Inc dividends
Adia Nutrition Inc has not paid dividends in the last 6 fiscal years.
Who owns Adia Nutrition Inc
Ownership data of Adia Nutrition Inc is not available yet.
Adia Nutrition Inc company profile
- Company name
- Adia Nutrition Inc
- Ticker
- ADIA.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Capital Markets
- Employees
- 3
- Fiscal year end
- December
- Address
- 1561 West Fairbanks Avenue, Winter Park, FL, United States, 32789
- Phone
- 321-231-2843
- Website
- adiamed.com
About Adia Nutrition Inc
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.
Adia Nutrition Inc management
5- Mr. Larry PowaliszCEO, President, Secretary & Chairman · born 1964
- Ms. Rebecca MillerChief Financial Officer · born 1976
- Ms. Jenny Angeloff SinghalCo-Founder
- Ms. April NugentCo-Founder
- Ms. Dawn BellChief Revenue Officer